Clinical Trial Update: Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial update on copper treatment in Menkes disease, related phenotypes, and unexplained copper deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menkes Disease
• Occipital Horn Syndrome
• Unexplained Copper Deficiency

Snippet

Sponsor: Cyprium Therapeutics, Inc. | Conditions: Menkes Disease, Occipital Horn Syndrome | Phase 3 | Status: COMPLETED